CD274 and neoplasm: It has been previously shown that a range of different chemotherapeutic agents can upregulate the expression of various immune checkpoint molecules such as PD-L1, which may have effects on chemoresistance as well as enhancing tumor evasion of the immune system in breast cancer33,34.